Table 2.
Distribution of lesions on each imaging modality. The first row for each N/M stage represents a comparison between patients who underwent BS, 18F-choline PET/CT, and WB-MRI (n = 33), and the second row represents a comparison between the patients who underwent BS and WB-MRI (n = 56)
| BS | 18F-choline PET/CT | WB-MRI | |
|---|---|---|---|
| N0 | – | 23/33 (69.7%) | 26/33 (78.8%) |
| – | – | 43/56 (76.8%) | |
| N1 | – | 10/33 (30.3%) | 7/33 (21.2%) |
| – | – | 13/56 (23.2%) | |
| M0 | 30/33 (90.9%) | 21/33 (63.6%) | 22/33 (66.7%) |
| 43/56 (76.8%) | – | 34/56 (60.7%) | |
| M1a | – | 6/33 (18.2%) | 3/33 (9.1%) |
| – | – | 6/56 (10.7%) | |
| M1b | 3/33 (9.1%) | 6/33 (18.2%) | 8/33 (24.2%) |
| 13/56 (23.2%) | – | 16/56 (28.6%) | |
| M1c | – | 0/33 (0%) | 0/33 (0%) |
| – | – | 0/56 (0%) |